Our paper describing how genetic variation can alter molecular response to treatments, including valproic acid a known environmental factor where prenatal exposure increases the likelihood of an autism diagnosis, was published in Molecular Psychiatry. Here, we demonstrate gene x environment interactions that could accentuate or temper the effects of a known teratogen. This study design may be useful to find why some individuals are more susceptible than others to the impacts of environmental exposures.